<DOC>
	<DOC>NCT01413360</DOC>
	<brief_summary>The investigators will evaluate the efficacy of high dose vitamin C in chronic hepatitis patients whose serum liver enzymes are elevated more than upper limit.</brief_summary>
	<brief_title>The Effect of High Dose Vitamin C on the Liver Function in Chronic Hepatitis Patients</brief_title>
	<detailed_description>The changes of laboratory findings including serum transaminase levels, serum albumin levels, Child-Pugh score, MELD score, and APRI score will be evaluated.</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis, Chronic</mesh_term>
	<mesh_term>Hepatitis C, Chronic</mesh_term>
	<mesh_term>Hepatitis, Alcoholic</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Ascorbic Acid</mesh_term>
	<criteria>1. Chronic hepatitis C patients positive antiHCV antibody more than 6 months serum alanine aminotransferase 40 80 IU/L for more than 6 months not indicated for antiviral therapy with interferon and ribavirin 2. Chronic alcoholic hepatitis significant alcohol drinking history and no other cause of chronic hepatitis serum alanine aminotransferase 40 80 IU/L for more than 6 months Chronic hepatitis B, autoimmune hepatitis, primary biliary cirrhosis, Wilson's disease, hemochromatosis, other chronic hepatitis except chronic hepatitis C or alcoholic hepatitis decompensated liver cirrhosis platelet &lt; 50,000/uL or white blood cell &lt; 1,500/uL need and willing for antiviral therapy significant renal dysfunction (GFR &lt; 30 mL/min/kg) or history of renal stone hepatotonic drug (i.e. silymarin, garlic oil, aronamin gold) usage within 2 weeks pregnancy, lactating woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>